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SIRT1 Promotes Differentiation of Normal Human
Keratinocytes
Gil Blander1,2, Anupama Bhimavarapu2, Thomas Mammone3, Daniel Maes3, Keith Elliston1,
Christian Reich1, Mary Steidl Matsui3, Leonard Guarente2 and Joseph Jorge Loureiro1
Sir2 regulates lifespan in model organisms, which has stimulated interest in understanding human Sir2 homolog
functions. The human Sir2 gene family comprises seven members (SIRT1–SIRT7). SIRT1, the human ortholog of
the yeast Sir2 by closest sequence similarity, is a nicotinamide adenine dinucleotide (NADþ )-dependent
deacetylase with enzymatic properties indistinguishable from the yeast enzyme. We studied the involvement
of SIRT1 in normal human keratinocyte physiology by a transcriptional microarray analysis of primary
keratinocytes either overexpressing or underexpressing SIRT1. Using a systems biology analytical approach,
we predicted that SIRT1 induces keratinocyte differentiation through a pathway integral to or overlapping with
that of calcium-induced differentiation. We experimentally assayed this prediction and found that the SIRT1
inhibitor nicotinamide inhibited expression of keratinocyte differentiation markers, whereas a SIRT1 activator,
resveratrol, enhanced expression of keratinocyte differentiation markers. Similar results were obtained in
keratinocytes manipulated to overexpress or underexpress SIRT1, and modulating SIRT1 significantly affected
keratinocyte proliferation rates. We conclude that SIRT1 functions in normal human keratinocytes to inhibit
proliferation and to promote differentiation.
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INTRODUCTION
Human SIRT1 (silent mating type information regulation 2
homolog 1) is a nicotinamide adenine dinucleotide (NADþ )-
dependent deacetylase controlling gene expression, cellular
metabolism, and cellular stress responses (Haigis and
Guarente, 2006). SIRT1 regulates adipocyte, muscle, liver,
and endocrine pancreas physiology (Fulco et al., 2003;
Picard et al., 2004; Rodgers et al., 2005; Bordone et al.,
2006). Modulation of SIRT1 activity in those tissues impacts
signaling networks, including insulin signals, controlling cell
metabolism, and stress responses (Rodgers et al., 2005;
Bordone et al., 2006). Additionally, SIRT1 has been shown
to regulate cell differentiation in both myocytes and white
adipocytes. Overexpressing SIRT1 negatively regulates their
differentiation, whereas SIRT1 RNA interference (RNAi)
enhances differentiation (Fulco et al., 2003; Picard et al.,
2004). This study expands on these findings by investigating
the role of human SIRT1 in skin cells using human primary
keratinocytes as a model system for skin biology. Computa-
tional systems biology methods are combined with laboratory
validation assays to develop a causal network model for
SIRT1 function in primary keratinocytes.
In model organisms including yeast, flies, and worms, the
SIRT1 ortholog Sir2 regulates lifespan (Kaeberlein et al.,
1999; Tissenbaum and Guarente, 2001; Rogina and Helfand,
2004; for review see Blander and Guarente, 2004). In yeast,
sir2 null mutants have shorter replicative lifespan and
overexpressing yeast sir2 extends their lifespan (Kaeberlein
et al., 1999). In worms and flies, overexpressing sir2 also
increases their lifespan, and in worms null sir2 mutations
decreases the lifespan (Tissenbaum and Guarente, 2001;
Rogina and Helfand, 2004; Viswanathan et al., 2005). An
ongoing aging-related research in mice indicates that SIRT1
is required for normal physiology, but specific effects on
lifespan remain to be determined (McBurney et al., 2003).
Given that SIRT1 homologs impact aging patterns, it is
important to determine the cell and molecular events that
SIRT1 controls in human skin cells.
Small molecule activators of SIRT1 have been identified
(Howitz et al., 2003). Of these, the most potent activator is
resveratrol, which is implicated in a number of health
benefits. Resveratrol increases lifespan in yeast, worms, and
flies (Howitz et al., 2003; Wood et al., 2004). In isolated
human cells, resveratrol increases cell survival after DNA
damage (Howitz et al., 2003). Also, resveratrol has recently
been shown to inhibit pig preadipocyte differentiation,
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whereas nicotinamide, a SIRT1 inhibitor, greatly stimulated
the proliferation and differentiation of pig preadipocytes
(Bai et al., 2008). Less is known about resveratrol effects in
other tissue contexts such as the skin.
To understand the function of SIRT1 in the skin, primary
human keratinocytes either overexpressing or underexpres-
sing SIRT1 were subjected to gene expression microarray
analysis. Using a systems biology approach, we determined
that SIRT1 overexpression recapitulates a molecular signa-
ture, which overlaps with epidermal differentiation in vivo,
whereas SIRT1 underexpression recapitulates a molecular
signature, which overlaps with epidermal proliferation
in vivo. Hypotheses developed in the systems level analysis
of microarray data were then assayed in vitro. In support of
these hypotheses, we found that inhibiting SIRT1 by either
RNAi or the chemical inhibitor nicotinamide repressed
keratinocyte differentiation while overexpressing or activat-
ing SIRT1-induced differentiation. Finally, when measuring
the replication capacity of these cells, we found that the
cells overexpressing SIRT1 replicated fewer times than their
controls whereas cells underexpressing SIRT1 replicated
more than their controls. These data strongly suggest that
SIRT1 is an important regulator of the keratinocyte differen-
tiation pathway and is a potential regulator of skin aging.
RESULTS
To investigate the role of SIRT1 in growth and differentiation
of normal human primary keratinocytes (NHEK), a microarray
analysis of SIRT1-overexpressing and SIRT1 knockdown
NHEK cells was conducted. For this purpose, four transgenic
keratinocyte populations were generated and characterized
as follows: SIRT1 overexpressing cells, pBABE-vector-
negative controls, SIRT1 RNAi-treated cells, and pSUPER-
RNAi-negative controls. SIRT1 protein overexpression and
knockdown is evident by western blot in the respective NHEK
transgenic cells, using actin and tubulin abundance as a loading
control (Figure 1a). These genetically modified NHEK cells pro-
vide an in vitro context for studying SIRT1 function in skin cells.
SIRT1-overexpressing and SIRT1 knockdown NHEK cells
were subject to a gene expression microarray analysis using
the Affymetrix U133a GeneChip technology. The microarray
data were collected (each of the four keratinocyte prepara-
tions was run in triplicate) for a total of 12 arrays measuring
22,278 probe sets in each microarray. The signals of the
SIRT1-overexpressing and SIRT1 knockdown cells were
compared with their respective controls using RMA (Robust
Multichip Average) analysis to determine which probe sets
were significantly different between experimental and
negative control groups. Significantly changed probe sets
had an adjusted P-value ofo0.05 and a fold change of41.3.
A total of 109 gene expression changes in the SIRT1-
overexpressing cells and 228 gene expression changes in
the SIRT1 knockdown cells were identified by these criteria
(Figure 1b). The observed transcriptional changes caused by
SIRT1 overexpression or knockdown in primary keratinocytes
form the basis for the systems-level causal network modeling.
Because both perturbations were performed on the same
cell type, an initial Venn analysis was performed comparing
the two microarray data sets to identify overlapping trans-
cripts changed in both experiments (Figure 1b). A total of
26 transcripts were modulated in both the SIRT1-over-
expressing and the SIRT1 knockdown NHEK cells (Figure
1b, orange). Of the 26 transcripts, the expressions of 21 trans-
cripts were modulated in opposite directions (Figure 1c;
Table 1). Twenty genes were increased and one was
decreased in the SIRT1-overexpressing cells. A survey of
this list of genes changed in both experiments identifies the
high number of keratinocyte differentiation markers (SPRR3,
SPRR1A, KRT1, KRT23, DSC1, DSG1, S100A8, S100A9,
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Figure 1. Gene expression changes induced by either overexpressing or
underexpressing SIRT1 in primary keratinocytes identify a subset of
expression changes oppositely affected by the two treatments (a) NHEK cells
were infected with one of the following: SIRT1 overexpression virus (OE, T1)
or its control virus (OE, C), SIRT1 RNAi virus (RNAi, T1) or its control virus
(RNAi, C). A western blot analysis of SIRT1 demonstrates overexpression and
reduced expression of SIRT1 relative to the tubulin and actin loading controls.
(b) Venn diagram of the SIRT1 overexpression (OE) and the SIRT1 RNAi
(RNAi) state changes. The OE and the RNAi experiments include 109 and 228
RNA expression state changes, respectively. Orange-colored region indicates
the overlapping OE and the RNAi state changes. (c) Scatter plot analysis of
genes affected by both treatments indicates that 21 of 26 are oppositely
modulated (orange sectors).
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FLG, IVL, and so on) (Table 1), suggesting increased cell
differentiation in the SIRT1-overexpressing cells. However, a
causal network analysis of all the data (109 gene expression
changes in SIRT1-overexpressing cells and 228 gene expres-
sion changes in SIRT1 knockdown cells) is required to better
understand the molecular network controlling these observed
gene expression changes.
Causal network modeling is a systematic analysis of an
entire ‘omic’ data set. To identify the cellular processes and
the molecular factors modulated in the SIRT1-overexpressing
and SIRT1 RNAi cells, the Genstruct Causal Modeling
platform was used to computationally derive a mechanistic
model for the observed gene expression changes (see the
Materials and Methods section for details). Automated causal
reasoning on the SIRT1 overexpression and SIRT1 knockdown
data yielded 15 and 74 statistically significant hypotheses,
respectively. We focused on those computationally derived
hypotheses that are evidenced in both experiments and
proposed to change in opposite directions, as these hypo-
theses suggest core SIRT1-dependent molecular networks.
Causal modeling identifies cell differentiation, calcium-
dependent processes, and the transcriptional activity of
peroxisome proliferator-activated receptor gamma (PPARG)
as cellular processes or molecular components mechanisti-
cally relevant to both experiments. All three hypotheses
are proposed upregulated in the SIRT1 overexpression and
downregulated in the SIRT1 knockdown experiment. These
three hypotheses and their supporting and conflicting micro-
array observations are displayed in Figure 2a for the SIRT1
overexpression and Figure 2b for the SIRT1 RNAi experiment.
These three hypotheses become the framework for under-
standing the molecular networks affected by SIRT1.
The network of hypotheses supporting increased cell
differentiation in the SIRT1-overexpressing cells are displayed
in Figure S1. In addition to the three core hypotheses, other
computationally derived hypotheses unique to each experi-
ment further delineate the molecular networks proposed by
causal modeling. Gene expression data support an increased
transcriptional activity of CCAAT/enhancer-binding protein
alpha (CEBPA) in the SIRT1-overexpressing primary kerati-
nocytes (Figure S1). CEBPA is a known PPARG-binding
protein that functions as a transcriptional coactivator to
PPARG. Further support for CEBPA activity in SIRT1 signaling
is suggested by the SIRT1 knockdown experiment, in which
CEBPA expression is observed decreased by SIRT1 knock-
down, supporting the proposed decreased transcriptional
activity of PPARG in SIRT1 knockdown cells (Figure 2b).
Even though there was no corresponding increase in CEBPA
transcription in the SIRT1-overexpressing cells, causal model-
ing, by identifying known CEBPA target genes observed
to change in a manner consistent with increased CEBPA
transcriptional activity, predicts increased CEBPA activity.
Table 1. Gene expressions oppositely affected by SIRT1 OE and knockdown (RNAi)
Gene symbol Gene title SIRT1 versus OE control RNAi versus RNAi control
SPRR3 Small proline-rich protein 3 2.06003 4.14393
SPRR1A Small proline-rich protein 1A 1.67404 2.97523
SERPINB3 Serpin peptidase inhibitor, clade B 1.78097 2.4144
SERPINB4 Serpin peptidase inhibitor, clade B 1.67404 1.77892
SPINK5 Serine peptidase inhibitor, Kazal type 5 1.52344 2.26524
SLPI Secretory leukocyte peptidase inhibitor 1.86176 2.74473
KRT1 Keratin 1 (epidermolytic hyperkeratosis) 5.32704 2.01391
KRT23 Keratin 23 1.54114 2.34947
DSC1 Desmocollin 1 3.06524 3.06312
DSG1 Desmoglein 1 3.25427 3.19393
S100A8 S100 calcium binding protein A8 1.98069 2.77599
S100A9 S100 calcium binding protein A9 1.84634 1.81252
FLG Filaggrin 1.52028 1.5533
IVL Involucrin 1.66094 2.20228
TGM1 Transglutaminase 1 1.54757 1.56663
CRABP2 Cellular retinoic acid binding protein 2 1.76826 1.57207
DEFB1 Defensin, beta 1 2.06146 1.87341
UPK1B Uroplakin 1B 1.75564 1.5049
DHRS9 Dehydrogenase/reductase 1.56085 1.54757
SCEL Sciellin 2.04202 1.66056
HS3ST2 Heparan sulfate 3-O-sulfotransferase 2 1.5351 1.56699
OE, overexpression.
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Figure 2. Causal network modeling of microarray observations predicts that increasing and decreasing SIRT1 levels in NHEK cells have opposite effects on
cell differentiation, calcium-mediated signaling, and the transcriptional activity of PPARG (a) In the SIRT1 overexpressing cells. (b) In the SIRT1 RNAi cells.
Diagram of RNA state changes consistent with or contrary to the indicated hypothesis. Green—observed increase in RNA expression of a given gene;
red—observed decrease in RNA expression of a given gene; yellow—hypothesized increase in biological processes or protein activity; blue—hypothesized
decrease in biological processes or protein activity. ‘‘þ ’’ symbolizes causal activation; ‘‘’’ symbolizes casual inhibition; ‘‘þ ’’ and ‘‘’’ nodes are supported
by published findings supporting the causal assertion between the hypothesis and the RNA state change. An ‘‘X’’ over an observed RNA expression change
indicates a contradiction (the direction of the observed RNA expression change is inconsistent with the hypothesis it is connected to). General note: In figures
where gene expression is depicted, expression is noted by ‘‘exp’’ and the NCBI gene symbol is in parentheses. For example, exp(KRT10) indicates a change
in keratin 10 expression. In addition, placement within a particular color indicates whether the change in expression was observed to increase (green) or
observed to decrease (red). Also predicted increase (yellow) or predicted decrease (blue) may also be indicated.
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The network of hypotheses supporting reduced cell
differentiation in the SIRT1 knockdown cells are displayed
in Figure S2. A causal analysis of the SIRT1 knock-
down experiment identified functionally relevant hypotheses
unique to that experiment. In addition to the three core
hypotheses, decreased retinoate signaling and increased cell
proliferation were inferred in that experiment (Figure S2).
Decreased retinoate signaling is consistent with reduced cell
differentiation, and because retinoate is a known activator
of PPARG activity, decreased retinoate signaling is also
consistent with decreased PPARG activity proposed in the
causal network model.
Causal modeling further predicts that cell cycle regulators,
particularly E2F1 and CCND1 (cyclin D1), are proposed to
increase their activity by SIRT1 knockdown (Figure S3). The
predicted increases in E2F1 and CCND1 activity are
supported by gene expression changes of known cell cycle
components, including MCM6 (mini chromosome mainte-
nance complex component 6), TTK (TTK protein kinase), and
PCNA (proliferating cell nuclear antigen) (Figure S3). In
summary, causal network modeling proposes that for SIRT1
knockdown in NHEK cells, decreased calcium, retinoate, and
PPARG activities, as well as increased cell cycle regulators
function in a molecular network that inhibits primary
keratinocyte differentiation and promotes cell proliferation.
Causal network modeling was used to develop a mecha-
nistic model of SIRT1 function in NHEK cells that provides a
rationale for further experimentation. To test the predicted
effects of SIRT1 modulation on NHEK cell differentiation,
NHEK cells were treated with either SIRT1 agonists or
antagonists. NHEK cells were incubated with nicotinamide
(NAA, a known SIRT1 inhibitor), H2O (a vehicle control for
nicotinamide treatment), resveratrol (a SIRT1 activator), or
DMSO (a vehicle control for resveratrol treatment), and the
NHEK cells were assayed for cell differentiation by measure-
ment of known keratinocyte differentiation markers. Western
blot analysis using anti-involucrin (and anti-actin as a total
protein loading control) indicates that the SIRT1 antagonist
NAA inhibits confluence-induced differentiation and that
the SIRT1 agonist resveratrol promotes cell differentiation
(Figure 3a). The quantification of the NAA-treated cells
revealed between 1.5- and 4-fold reductions in involucrin
abundance in the 100% confluent and between 1.5- and 3.5-
fold in þ3 days time points (Figure 3a and b). The quanti-
fication of the resveratrol-treated cells revealed between
1.5- and 2-fold increase in the involucrin intensity in the
þ 3-day time point (Figure 3a and c). Although not meeting
the statistical significance level (t-test, Po0.05), resveratrol
treatment trended toward increasing normalized involucrin
abundance (t-test, P¼ 0.058). A valid possibility is that the
resveratrol differentiation effect is due to inhibition or acti-
vation of its other targets (Baur and Sinclair, 2006). Thus, as
predicted by causal modeling, SIRT1 pharmacological
antagonist inhibits NHEK cell differentiation whereas SIRT1
pharmacological agonist trend toward promoting NHEK cell
differentiation.
Another cellular process predicted to increase in the
SIRT1-overexpressing cells and to decrease in the SIRT1
knockdown cells is calcium-mediated signal transduction, a
potent inducer of keratinocyte differentiation (Sharpe et al.,
1989). To test the role of SIRT1 in calcium (Ca2þ )-dependent
NHEK cell differentiation, SIRT1-overexpressing and SIRT1
knockdown cells were treated with calcium and assayed
by measuring keratinocyte differentiation markers. Western
blots of these cells before Ca2þ addition, 1 day after Ca2þ
addition, and 3 days after Ca2þ addition revealed that the
cells overexpressing SIRT1 expressed higher levels of cross-
linked involucrin than did their controls (Figure 4a). The
quantification of involucrin in the SIRT1-overexpressing
cells revealed between 1-and 3.5-fold increase at day 0,
1.5- to 3-fold increase at day 1, and 3- to 5-fold increase at
day 3 (Figure 4a and c). Additionally, SIRT1 overexpres-
sion had an additive effect with calcium in this experiment
(Figure 4a, compare SIRT1 overexpression (OE) day 0
with day 3). Conversely, the SIRT1 knockdown (SIRT1
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Figure 3. SIRT1 activation and SIRT1 inhibition have opposite effects on
keratinocyte differentiation (a) NHEK cells treated with growth media
(Control); nicotinamide (NAA) (8mM), a SIRT1 inhibitor; DMSO, a control for
resveratrol; resveratrol (RES) (3 mM), a SIRT1 activator. Cells were harvested
at 80% confluence (80), 100% confluence (100), or 3 days after 100%
confluence (þ 3D). A western blot was performed to determine the levels
of involucrin and actin. (b and c) Statistical analysis of three biological
replicates for NAA- and Res-treated NHEK cells shown in panel a. Panels b
and c mean±SEM for each treatment. NAA treatment reduces normalized
involucrin abundance (t-test, Po0.05), and although not meeting the
same level of statistical significance, resveratrol treatment trended toward
increasing normalized involucrin abundance (t-test, P¼ 0.058).
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RNAi-infected) cells had less cross-linked involucrin com-
pared with the RNAi controls, which indicates less
cell differentiation (Figure 4b). The quantification of involu-
crin levels in the SIRT1 RNAi cells revealed a 2-fold decrease
at day 0, a 1.5- to 3-fold decrease at day 1, and a 2.5- to
7-fold decrease at day 3 (Figure 4b and d). Thus, these
biochemical findings confirmed that calcium-dependent
signaling is related to SIRT1 function, and that reducing
SIRT1 abundance inhibits Ca2þ -mediated signals controlling
cell differentiation.
Finally, the role of SIRT1 in cell proliferation was examined.
The proliferation rates of NHEK cells overexpressing or
underexpressing SIRT1 were compared with negative control
NHEK cells. As shown in Figure 5a, in a span of 45 days, the
SIRT1-overexpressing NHEK cells went through only 7.2
population doublings (PDs) whereas their control cells went
through 10.1 PDs; in the same length of time, the NHEK cells
infected with the SIRT1 RNAi underwent 12.4 PDs whereas
their control cells went through 9.3 PDs. Statistical analysis of
five replicates at day 5 supports this conclusion (Figure 5b).
Thus, as inferred by causal network modeling, SIRT1 limits the
rate of human keratinocyte proliferation.
DISCUSSION
Sir2 homologs are known regulators of aging, structurally
conserved from yeast to humans (for review see Blander and
Guarente, 2004). Although it is known that SIRT1, the human
Sir2 ortholog, controls differentiation in adult mammalian
tissues such as muscle and white adipose, it has been less
clear how SIRT1 functions in the maintenance of skin. In the
present study, we characterize by gene expression microarray
the molecular signaling networks occurring in primary
keratinocytes experimentally manipulated to either over-
express or underexpress SIRT1. Such an approach generates a
large gene expression change data set calling for a systems
level analysis. Causal modeling uses artificial intelligence
algorithms to generate hypotheses relevant to the observed
microarray data. In this study, we followed-up these
hypotheses by testing them in cultured human epidermal
keratinocytes. We demonstrated in vitro that SIRT1 controls
keratinocyte proliferation and differentiation, and that
calcium-induced keratinocyte differentiation requires SIRT1.
Using causal modeling of the gene expression microarray
data, we inferred that SIRT1 inhibits keratinocyte proliferation.
To test this cell proliferation hypothesis, we measured the
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replication capacity of the SIRT1 overexpression and SIRT1
knockdown keratinocytes. Reducing SIRT1 expression in
keratinocytes increased their proliferation rate, whereas over-
expressing SIRT1 inhibited proliferation (Figure 5a and b).
Consistent with the causal model for SIRT1 function developed
in this study, SIRT1 has recently been shown to bind E2F1 and
to inhibit E2F1 transactivation activity (Wang et al., 2006). In
summary, the SIRT1 effect on keratinocyte proliferation might
work via the inhibition of E2F1 activity.
Causal network modeling of the microarray data proposes
that SIRT1 overexpression promotes cell differentiation and
SIRT1 knockdown inhibits cell differentiation. To test the cell
differentiation hypothesis, we have measured the differentiation
dynamics of keratinocytes overexpressing or underexpressing
SIRT1 by assaying for keratinocyte differentiation markers.
Indeed, SIRT1 overexpression promotes keratinocyte differen-
tiation and SIRT1 knockdown blocks keratinocyte differentia-
tion. Similar effects are seen in keratinocytes treated with
nicotinamide, a SIRT1 antagonist, and polyphenol resveratrol, a
putative SIRT1 agonist. Interestingly, other polyphenols such as
epigallocatechin-3-gallate also appear to increase human
keratinocyte differentiation (Hsu et al., 2003; Eckert et al.,
2006). In conclusion, SIRT1 induces keratinocyte differentia-
tion, as predicted by causal network modeling.
The effect of SIRT1 on keratinocytes differentiation is the
opposite of what is observed in muscle and fat cells. SIRT1
overexpression in muscle and fat cells actually inhibits
differentiation (Fulco et al., 2003; Picard et al., 2004). Again,
this may reflect fundamental differences in the physiology of
these tissues. For example, SIRT1 in keratinocytes may regu-
late a different set of transcription factors or cofactors in the
skin compared with muscle and fat cells. SIRT1 inhibits
adipocyte differentiation by repressing PPARG by interacting
with NCOR1 (nuclear receptor co-repressor 1) (Picard et al.,
2004). One possibility is that adipocytes and keratinocytes
express different PPARG cofactors. In the keratinocytes,
SIRT1 might activate PPARG by binding and activating
CEBPA, a PPARG agonist. Consistent with this, SIRT1 binds
and regulates CEBPA function (Qiao and Shao, 2006).
Another possibility is that in the keratinocytes SIRT1 might
activate PPARG by direct deacetylation.
Increased intracellular Ca2þ is a known promoter of
keratinocyte differentiation both in vivo and in vitro (Tu et al.,
2004). Causal network modeling identified increased Ca2þ as a
hypothesis in the SIRT1-overexpressing cells and decreased
Ca2þ as a hypothesis in the SIRT1 knockdown cells. To test the
Ca2þ hypothesis, we measured the differentiation capacity of
cells with higher and lower SIRT1 protein levels and found that
calcium-induced keratinocyte differentiation was all but entirely
blocked in SIRT1 knockdown cells and activated in SIRT1-
overexpressing cells. In fact, SIRT1 overexpression itself was
sufficient to trigger keratinocyte differentiation. This suggests
that SIRT1 is an important effector of intracellular Ca2þ -
mediated signals controlling differentiation. However, it cannot
be excluded based on this experimental evidence that Ca2þ
and SIRT1 may also have some independent regulatory
functions controlling the differentiation of primary keratinocytes.
In conclusion, causal network modeling of gene expres-
sion microarray data followed by experimental validation
provides evidence that SIRT1 promotes keratinocyte differen-
tiation acting downstream of Ca2þ . Additionally, SIRT1
negatively regulates human keratinocyte proliferation, which
might work via E2F1 inhibition. Our findings have implica-
tions for understanding the maintenance of the skin in healthy
individuals, and may be important to the understanding of
skin diseases characterized by hyperproliferation and under-
differentiation, such as psoriasis.
MATERIALS AND METHODS
Cells
NHEK cells obtained from Cascade Biologics (Portland, OR), and
maintained under standard conditions in Epilife Medium with Ca2þ
(Cascade Biologics) and supplemented with human keratinocyte
growth supplement (Cascade Biologics).
Plasmids
SIRT1 RNAi plasmids constructed using pSUPER-RETRO (Oligo
Engine, Seattle, WA) using the SIRT1 siRNA sequence GGAAATATA
TCCTGGACAA. SIRT1 was overexpressed using pBabePuro.
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Figure 5. SIRT1 downregulation increases and SIRT1 upregulation decreases
the replicative lifespan of human keratinocytes in culture (a) Example
lifespan of NHEK cells overexpressing or underexpressing SIRT1 is shown.
After infection and selection, cells were counted and were seeded for the
lifespan experiment. PD (population doubling) was determined by the
formula: PD¼ (log Nflog Ni)/log2, where Nf is the number of cells
counted and Ni the number of cells seeded. (b) Statistical analysis of five
biological replicates (mean±SEM) for SIRT1 overexpression and RNAi,
respectively, indicates that the two treatments have opposite effects on
cell growth (t-test, Po0.05 for each).
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Infection
NHEK cells were infected for 3–6 hours and selected with puromycin
(0.5 mM) for 3 days.
Differentiation assay (Ca2þ )
Control cells were incubated without additional Ca2þ (0.00065mM
supplied in the media), whereas the treated cells were incubated
with 1.6mM Ca2þ , samples were harvested at days 0, 1, and 3. The
experiment was run in triplicate.
Differentiation assay (confluency) and treatment with SIRT1
inhibitor and activator
The concentration of nicotinamide in the medium was 8mM and the
concentration of resveratrol in the medium was 3 mM (DMSO used as
a solvent control). For each treatment, one plate was harvested
at 80% confluency, another at 100% confluency, and the last 3 days
after 100% confluency. The experiment was run in triplicate.
Western blot analysis
The harvested NHEK cells were lysed in protein sample buffer and
separated by SDS-PAGE, transferred to nitrocellulose, and incubated
as indicated (SIRT1 polyclonal antibody (custom-made in labora-
tory), involucrin mAb (Neomarkers, Fremont, CA), actin C-4
antibody (Sigma, St Louis, MO) or a KRT10 antibody (Labvision,
Fremont, CA)). The densitometric analysis was performed on
scanned images of western blots using ImageJ software (NIH Image
analysis website http://rsb.info.nih.gov/ij/). Quantification provided
as the ratio to actin abundance as a normalization control.
Cellular growth
For each condition tested, NHEK cells were seeded at a 200,000
cells per 6 cm plate. Upon reaching 80% confluency, these cells
were counted and then split. PD was determined by the formula:
PD¼ (log Nflog Ni)/log2, where Nf is the number of cells counted
and Ni the number of cells seeded. Two long-term trials and four
short-term trials were conducted.
GeneChip hybridizations
Three replicates of each sample (SIRT1 overexpression, vector
control, SIRT1 RNAi, and RNAi control) were hybridized to
GeneChip arrays (HG-U133A_2, Affymetrix, Santa Clara, CA).
Hybridizations and scanning were carried out at the MIT BioMicro
Center.
Image and data analysis
To enable direct GeneChip comparisons, data were normalized
using RMA (Irizarry et al., 2003). Fold changes were calculated by
dividing the average intensity values of the experimental samples
(either RNAi or overexpression) by the average of the reference
control samples.
Causal network modeling (automated hypothesis generation
using reverse causal analysis)
Reverse causal reasoning interrogates the human knowledge assembly
model to identify upstream controllers (hypotheses) for the transcrip-
tional changes observed by microarray analysis (RNA state changes).
Each hypothesis is scored according to two probabilistic scoring
metrics, richness, and concordance, which examine distinct aspects
of the probability of a hypothetical cause explaining a given number
of RNA state changes. Richness is the probability that the number of
observed RNA state changes connected to a given hypothesis could
have occurred by chance alone. Concordance is the probability that
the number of observed RNA state changes that match the
directionality of the hypothesis (e.g., increased or decreased kinase
activity for a kinase and increased or decreased transcriptional activity
for a transcription factor) could have occurred by chance alone. A
hypothesis is considered to be statistically significant if it meets
richness and concordance cutoffs of Po0.05. Automated reverse
causal reasoning on the SIRT1 overexpression and SIRT1 knockdown
data yielded 15 and 74 statistically significant hypotheses, respec-
tively, which were further investigated and prioritized by evaluation of
their biological relevance to the experimental context. Causal links
between biologically relevant hypotheses were identified and
integrated into a causal network model for the role of SIRT1 in
primary keratinocytes.
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SUPPLEMENTARY MATERIAL
Figure S1. Causal model for SIRT1-induced keratinocyte differentiation.
Figure S2. Causal model for SIRT1-induced keratinocyte differentiation.
Figure S3. Cell cycle hypothesis in the SIRT1 RNAi cells. As in Figure 2.
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